biologic

简明释义

英[ˌbaɪəʊˈlɒdʒɪk]美[ˌbaɪəˈlɑːdʒɪk]

adj. 生物的；生物学的

英英释义

单词用法

同义词

反义词

例句

1.There has been no clear biologic explanation for the lower risk of diabetes seen with higher dairy consumption in prior studies.

在先前的研究中，对于乳制品的高消耗能降低患糖尿病风险这点并没有给予明确的生物学解释。

2.Only a future mechanism of disease study with a biologic marker for depression can clearly identify which of the . . . hypotheses is most pertinent.

只有将来采用抑郁生物学标志的疾病机制研究才能明确哪一种假设是最贴切的”。

3.Since 1997 the FDA received 13 reports of death related to the use of glucose testing strips and biologic drug formulations.

自1997年以来，FDA已经收到13例与使用血糖检测试纸及生物药物有关的死亡病例报道。

4.We believe that direct head-to-head comparisons of biologic drugs in patients suffering from RA are needed.

我们相信在RA病人中直接头对头比较的生物制剂是需要的。

5.Moreover, with the characteristics of biologic form, the author explore the essential rules of biologic form simplification.

在此基础上结合生物形态的特点，探究生物形态简化的本质规律。

6.The researchers examined urine samples from the subjects and tried to figure out if a biologic marker known as NNAL could predict cases of lung cancer.

研究人员对受试者的尿样进行了检测，试图寻找一种叫做NNAL的生物标记，这种标记可以看作是肺癌的前兆。

7.Understanding the biologic 生物学的 mechanisms of aging can help develop better healthcare solutions.

理解衰老的生物学的机制可以帮助开发更好的医疗保健解决方案。

8.The biologic 生物制剂 therapies have shown promise in treating autoimmune diseases.

这种生物制剂疗法在治疗自身免疫性疾病方面显示出希望。

9.The new drug is designed to target specific biologic 生物学的 pathways in cancer cells.

这种新药旨在针对癌细胞中特定的生物学的生物学的通路。

10.Researchers are studying the biologic 生物的 effects of climate change on marine life.

研究人员正在研究气候变化对海洋生物的生物的影响。

11.She works in a lab that focuses on biologic 生物学的 research related to infectious diseases.

她在一个专注于传染病相关生物学的研究的实验室工作。

作文

In recent years, the field of medicine has seen a significant shift towards the use of biologics. Biologics are products that are made from living organisms or contain components of living organisms. They can include a wide range of products such as vaccines, blood components, gene therapies, and tissues. The growing interest in biologics is largely due to their potential to treat diseases that were previously considered untreatable. For instance, biologics have revolutionized the treatment of conditions like rheumatoid arthritis and certain types of cancer. This shift from traditional small-molecule drugs to biologic therapies represents a major advancement in the medical field.One of the most compelling aspects of biologics is their ability to target specific pathways in the body. Unlike conventional medications that often affect multiple systems, biologics can be designed to interact with particular cells or proteins, leading to more effective and personalized treatments. This specificity reduces the risk of side effects, which is a common issue with many traditional pharmaceuticals. Furthermore, the development of biologics is often driven by advances in biotechnology, allowing for innovative solutions to complex health issues.However, the production of biologics is not without its challenges. The processes involved in creating these therapies are complex and require stringent regulatory oversight. Ensuring the safety and efficacy of biologics is paramount, as any contamination or deviation in the manufacturing process can lead to significant health risks. Additionally, the high cost of biologic therapies poses another challenge, limiting accessibility for many patients who could benefit from these advanced treatments.Despite these challenges, the future of biologics looks promising. Research continues to explore new ways to utilize biologic therapies for an array of diseases, including autoimmune disorders, infectious diseases, and even genetic conditions. Innovations in genetic engineering, such as CRISPR technology, are paving the way for the development of novel biologics that can provide targeted interventions at the genetic level.In conclusion, the rise of biologics marks a transformative era in medicine. As we continue to deepen our understanding of biology and harness the power of living organisms, the potential for biologic therapies to improve patient outcomes is immense. The journey of biologics from the laboratory to the clinic is a testament to human ingenuity and the relentless pursuit of better health solutions. Embracing this new frontier in medicine will undoubtedly lead to breakthroughs that can change lives, making biologics an essential component of modern healthcare. Therefore, it is crucial for both healthcare professionals and patients to stay informed about these advancements and their implications for treatment options. As we look forward to the future, the role of biologics in healthcare will only continue to expand, offering hope to those in need of effective therapies.

近年来，医学领域已显著转向使用生物制剂。生物制剂是由活生物体制造或包含活生物体成分的产品。它们可以包括疫苗、血液成分、基因疗法和组织等多种产品。对生物制剂日益增长的兴趣主要源于其治疗以前被认为无法治愈的疾病的潜力。例如，生物制剂彻底改变了类风湿性关节炎和某些类型癌症的治疗。这种从传统小分子药物到生物制剂疗法的转变代表了医学领域的一项重大进步。生物制剂最引人注目的一个方面是其能够针对身体特定通路的能力。与常规药物通常影响多个系统不同，生物制剂可以设计为与特定细胞或蛋白质相互作用，从而导致更有效和个性化的治疗。这种特异性减少了副作用的风险，而这是许多传统药物常见的问题。此外，生物制剂的开发通常受到生物技术进步的推动，允许对复杂健康问题提供创新解决方案。然而，生物制剂的生产并非没有挑战。制造这些疗法所涉及的过程复杂，并需要严格的监管监督。确保生物制剂的安全性和有效性至关重要，因为任何污染或制造过程中的偏差都可能导致重大的健康风险。此外，生物制剂疗法的高成本也是另一个挑战，限制了许多可能受益于这些先进治疗的患者的可及性。尽管面临这些挑战，生物制剂的未来依然光明。研究继续探索利用生物制剂疗法治疗各种疾病的新方法，包括自身免疫性疾病、传染病，甚至遗传性疾病。基因工程的创新，如CRISPR技术，为开发新的生物制剂提供了途径，这些生物制剂可以在基因水平上提供靶向干预。总之，生物制剂的崛起标志着医学的变革时代。随着我们继续加深对生物学的理解并利用活生物体的力量，生物制剂疗法改善患者结果的潜力是巨大的。从实验室到临床的生物制剂旅程证明了人类的聪明才智和对更好健康解决方案的不懈追求。拥抱医学这一新前沿无疑将导致改变生命的突破，使生物制剂成为现代医疗保健的重要组成部分。因此，医疗专业人员和患者都必须及时了解这些进展及其对治疗选择的影响。展望未来，生物制剂在医疗保健中的作用只会继续扩大，为那些需要有效疗法的人们带来希望。